muc-2-globo h-klh conjugate vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 1997 (NCT00698711)
Timeline
1990s
- Jan 1, 1997
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- muc-2-globo h-klh conjugate vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00036933 | Phase 1 | Mar 1, 2002 | Cornell University, National Cancer Institute (NCI) |
| NCT00016146 | Phase 1 | Jul 1, 2000 | Cornell University, National Cancer Institute (NCI) |
| NCT00698711 | Phase 1 | Nov 1, 1997 | Cornell University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 3 | 3 | 1 | 1997 |
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2000 |
2 organizations
Page 1 / 1